Vaxcyte Ownership | Who Owns Vaxcyte?


OverviewForecastRevenueFinancialsChartTranscripts

Vaxcyte Ownership Summary


Vaxcyte is owned by 109.46% institutional investors, 0.50% insiders. Fmr is the largest institutional shareholder, holding 13.79% of PCVX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.94% of its assets in Vaxcyte shares.

PCVX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVaxcyte109.46%0.50%-9.96%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr16.17M13.79%$1.22B
Blackrock9.94M8.48%$750.56M
Vanguard group9.80M8.36%$739.77M
Janus henderson group8.87M7.56%$669.72M
Ra capital management8.20M7.00%$619.47M
Wellington management group llp4.59M3.92%$346.82M
Capital research global investors4.13M3.53%$312.12M
T. rowe price investment management4.02M3.43%$303.75M
State street3.37M2.87%$254.25M
Price t rowe associates inc /md/3.17M2.71%$239.61M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pivotal bioventure partners investment advisor793.04K46.04%$59.88M
Darwin global management2.08M19.07%$163.92M
Ra capital management8.20M8.19%$619.47M
Acuta capital partners110.40K7.02%$8.34M
Commodore capital lp1.30M6.73%$98.54M
Saturn v capital management215.68K6.15%$16.29M
Cormorant asset management, lp1.10M4.80%$83.06M
Kynam capital management, lp753.24K4.39%$56.88M
Frazier life sciences management1.04M3.67%$78.49M
Novo950.00K3.60%$71.73M

Top Buyers

HolderShares% AssetsChange
Janus henderson group8.87M0.36%1.20M
Norges bank984.46K0.01%984.46K
T. rowe price investment management4.02M0.19%469.62K
Commodore capital lp1.30M6.73%445.00K
Blackrock9.94M0.02%426.84K

Top Sellers

HolderShares% AssetsChange
Darwin global management2.08M19.07%-669.86K
Paradigm biocapital advisors lp627.20K1.81%-612.79K
Braidwell lp808.30K1.91%-404.40K
Pictet asset management sa532.90K0.05%-328.67K
Wellington management group llp4.59M0.06%-326.30K

New Positions

HolderShares% AssetsChangeValue
Norges bank984.46K0.01%984.46K$74.34M
Balyasny asset management418.71K0.06%418.71K$31.62M
Brown advisory367.22K0.04%367.22K$27.73M
Clearbridge investments186.14K0.01%186.14K$14.06M
Macquarie group159.01K0.01%159.01K$12.01M

Sold Out

HolderChange
Massmutual trust co fsb/adv-7.00
Lynx investment advisory-26.00
Fintrust capital advisors-27.00
Innealta capital-45.00
Quantbot technologies lp-57.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202434425.09%135,391,30510.49%1091.00%21032.08%8818.92%
Jun 30, 20242755.36%122,540,4573.83%1040.94%1597.43%74-6.33%
Mar 31, 202426114.47%118,023,70414.54%1050.94%14818.40%7916.18%
Dec 31, 202322811.22%103,039,9662.47%1061.08%12513.64%6817.24%
Sep 30, 2023205-0.97%100,552,5330.28%980.95%110-24.14%5848.72%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.65M2.94%-15.60K
iShares Russell 2000 ETF3.07M2.47%-6.90K
Vanguard Small Cap Index2.90M2.33%5.70K
Vanguard Health Care Inv2.55M2.06%225.47K
American Funds SMALLCAP World A2.38M1.92%-356.84K
Vanguard Institutional Extnd Mkt Idx Tr1.67M1.34%-7.88K
Vanguard Small Cap Growth Index Inv1.59M1.28%-4.47K
Janus Concentrated Growth CF1.52M1.23%1.52M
Fidelity Growth Compy Commingled Pl S1.42M1.15%54.19K
Janus Henderson Enterprise D1.38M1.12%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 18, 2024GUGGENHIME ANDREW PRESIDENT AND CFOSell$281.96K
Dec 18, 2024GUGGENHIME ANDREW PRESIDENT AND CFOSell$25.27K
Dec 18, 2024GUGGENHIME ANDREW PRESIDENT AND CFOSell$103.83K
Dec 18, 2024GUGGENHIME ANDREW PRESIDENT AND CFOSell$299.19K
Dec 09, 2024PICKERING GRANT CHIEF EXECUTIVE OFFICERSell$88.47K

Insider Transactions Trends


DateBuySell
2024 Q4-68
2024 Q3-54
2024 Q2-46
2024 Q1-70
2023 Q4-37

PCVX Ownership FAQ


Who Owns Vaxcyte?

Vaxcyte shareholders are primarily institutional investors at 109.46%, followed by 0.50% insiders and -9.96% retail investors. The average institutional ownership in Vaxcyte's industry, Biotech Stocks , is 47.04%, which Vaxcyte exceeds.

Who owns the most shares of Vaxcyte?

Vaxcyte’s largest shareholders are Fmr (16.17M shares, 13.79%), Blackrock (9.94M shares, 8.48%), and Vanguard group (9.8M shares, 8.36%). Together, they hold 30.62% of Vaxcyte’s total shares outstanding.

Does Blackrock own Vaxcyte?

Yes, BlackRock owns 8.48% of Vaxcyte, totaling 9.94M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 750.56M$. In the last quarter, BlackRock increased its holdings by 426.84K shares, a 4.49% change.

Who is Vaxcyte’s biggest shareholder by percentage of total assets invested?

Pivotal bioventure partners investment advisor is Vaxcyte’s biggest shareholder by percentage of total assets invested, with 46.04% of its assets in 793.04K Vaxcyte shares, valued at 59.88M$.

Who is the top mutual fund holder of Vaxcyte shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Vaxcyte shares, with 2.94% of its total shares outstanding invested in 3.65M Vaxcyte shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools